Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.48 |
| ▸ | RECQL | P46063 | 3/20 | 0.48 |
| ▸ | HPGD | P15428 | 3/20 | 0.42 |
| ▸ | ERN1 | O75460 | 2/20 | 0.39 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 3/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.37 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | CASP1 | P29466 | 2/20 | 0.37 |
| ▸ | CASP7 | P55210 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | TTR | P02766 | 2/20 | 0.37 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29957125 | 0.85 | TSHR (0.52) | TSHRALDH1A1HSD17B10CYP3A4RECQL | |
| SCHEMBL1425551 | 0.85 | TSHR (0.52) | TSHRALDH1A1HSD17B10CYP3A4RECQL | |
| SCHEMBL30905945 | 0.83 | RAPGEF4 (0.39) | TSHRALDH1A1HSD17B10CYP3A4RECQL | |
| SCHEMBL14919625 | 0.78 | IDO1 (0.33) | TTRCA1 | |
| SCHEMBL12781052 | 0.78 | CA2 (0.35) | TSHRALDH1A1ERN1KMT2AMAPT | |
| SCHEMBL24425038 | 0.78 | ALDH1A1 (0.34) | TSHRALDH1A1HSD17B10CYP3A4RECQL | |
| SCHEMBL13744875 | 0.78 | ERN1 (0.44) | TSHRALDH1A1HSD17B10CYP3A4RECQL | |
| SCHEMBL29955180 | 0.78 | ERN1 (0.44) | TSHRALDH1A1HSD17B10CYP3A4RECQL | |
| SCHEMBL29955692 | 0.78 | ALDH1A1 (0.34) | TSHRALDH1A1HSD17B10CYP3A4RECQL | |
| SCHEMBL4889444 | 0.75 | ALDH1A1 (0.50) | TSHRALDH1A1HSD17B10CYP3A4RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100330686-A1 | NANOSENSOR FOR SUGAR DETECTION | PARK SEUNG BUM | 2010-12-30 | — | — | US | claimed |
| US-20250206724-A1 | SUBSTITUTED 3-AMINO INDAZOLE DERIVATIVES AS KINASE INHIBITORS | NERVIANO MEDICAL SCIENCES S.R.L. (IT) | 2025-06-26 | — | — | US | disclosed |
| EP-4499612-A1 | SUBSTITUTED 3-AMINO INDAZOLE DERIVATIVES AS KINASE INHIBITORS | Nerviano Medical Sciences S.r.l. (IT) | 2025-02-05 | — | — | EP | disclosed |
| CN-118974020-A | Substituted 3-aminoindazole derivatives as kinase inhibitors | 内尔维亚诺医疗科学公司 | 2024-11-15 | — | — | CN | disclosed |
| CN-112204026-B | Polycyclic compound and organic light emitting diode including the same | 株式会社LG化学 | 2024-05-07 | — | — | CN | disclosed |
| WO-2023186773-A1 | SUBSTITUTED 3-AMINO INDAZOLE DERIVATIVES AS KINASE INHIBITORS | NERVIANO MEDICAL SCIENCES S.R.L. (IT) | 2023-10-05 | — | — | WO | disclosed |
| CN-115850021-A | Preparation method of polychlorinated biphenyl standard substance | 上海安谱实验科技股份有限公司 | 2023-03-28 | — | — | CN | disclosed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| CN-112204026-A | Polycyclic compound and organic light emitting diode comprising same | 株式会社LG化学 | 2021-01-08 | — | — | CN | disclosed |
| EP-2758380-B1 | BENZOIC ACID DERIVATIVES AS EIF4E INHIBITORS | HOFFMANN LA ROCHE (CH) | 2015-10-21 | — | — | EP | disclosed |
| US-20040220146-A1 | Methods and compositions for treating fungal infections | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2004-11-04 | — | — | US | disclosed |
| EP-1416799-A1 | METHODS AND COMPOSITIONS FOR TREATING FUNGAL INFECTIONS | Ramot at Tel Aviv University Ltd. (IL) | 2004-05-12 | — | — | EP | disclosed |
| US-6713471-B1 | SUCH AS TERT-BUTYL-1-METHYL-6,7,9,12-TETRAHYDRO-5H-PYRIDO-(4,3-B)(1,4) THIAZEPINO(2,3,4-HI)INDOLE-11(10H)-CARBOXYLATE; SEROTONIN AGONISTS AND ANTAGONISTS; CENTRAL NERVOUS SYSTEM DISORDERS | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2004-03-30 | — | — | US | disclosed |
| WO-2003009689-A1 | METHODS AND COMPOSITIONS FOR TREATING FUNGAL INFECTIONS | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2003-02-06 | — | — | WO | disclosed |
| US-20030009046-A1 | Preparation of preparing substituted indanones | EQUISTAR CHEMICALS, LP | 2003-01-09 | — | — | US | disclosed |
| EP-1192165-A2 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES | Bristol-Myers Squibb Pharma Company (US) | 2002-04-03 | — | — | EP | disclosed |
| WO-2000077010-A2 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES | DU PONT PHARMACEUTICALS COMPANY (US) | 2000-12-21 | — | — | WO | disclosed |
| EP-0626016-B1 | CHEMILUMINESCENT ENHANCERS | BRITISH TECH GROUP (GB) | 1998-06-03 | — | — | EP | disclosed |
| US-5629168-A | Chemiluminescent enhancers | BRITISH TECHNOLOGY GROUP LIMITED (GB) | 1997-05-13 | — | — | US | disclosed |
| WO-1993016195-A1 | CHEMILUMINESCENT ENHANCERS | BRITISH TECHNOLOGY GROUP LTD. (GB) | 1993-08-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250206724-A1 | SUBSTITUTED 3-AMINO INDAZOLE DERIVATIVES AS KINASE INHIBITORS | CDK1, CDK11A, CDK3 | TSHR 3696/4885ALDH1A1 4385/4885HSD17B10 3713/4885 |
| US-20040220146-A1 | Methods and compositions for treating fungal infections | ERG28, BLVRB, MANBA | TSHR 4713/4885ALDH1A1 3928/4885HSD17B10 2647/4885 |
| US-20030009046-A1 | Preparation of preparing substituted indanones | CYP1A2, CYP1B1, CYP1A1 | TSHR 4667/4885ALDH1A1 198/4885HSD17B10 547/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.